Regenxbio Inc at Stifel Healthcare Conference Transcript
All right. Good afternoon, everyone, we're going to get started here. We've got REGENXBIO presenting with us today. And it's our pleasure to have Kenneth Mills CEO; and Steve Pakola...
CMO.
CMO, I knew that. And maybe I can just give you a couple of minutes, you can give us a quick overview and then we can just touch into questions.
Sounds great. Thanks for having us. And we are an AAV gene therapy company that has been focused on the development of treatments in retinal diseases as well as muscle disorder for -- been public since 2015, we have a significant partnership that we started in 2021 with AbbVie that has helped launch our RGX-314 and now ABBV-RGX-314
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
